Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB)
Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB): A Stepped Wedge Clinical Trial Evaluating the Effectiveness of a Centralized S. Aureus Management Model
University of Alberta
1,800 participants
May 1, 2024
INTERVENTIONAL
Conditions
Summary
Staphylococcus aureus bacteremia (SAB) is associated with high morbidity and mortality rates with an incidence disproportionately higher in vulnerable populations. Management according to evidence-based care parameters, in particular Infectious Diseases (ID) consultation, is associated with improved mortality. SAB management is suboptimal in Alberta compared to other jurisdictions. An Alberta-based pilot study confirmed that timely recommendations to optimize SAB care, including ID consultation, was associated with improved adherence to all evidence-based quality-of-care indicators. Leveraging this pilot work, the investigators aim to implement OPTIMUS-SAB, an enhanced model of the pilot, to optimize and standardize SAB management across Alberta. The implementation study will be a zone-based acute care site stepped wedge design. OPTIMUS-SAB will consist of a centralized SAB care team whom will receive automated notification of all blood cultures positive for S. aureus allowing them to review the patient's medical chart and make preliminary management recommendations according to an evidence-based care bundle. The investigators will evaluate adherence to evidence-based SAB quality-of-care indicators before and after OPTIMUS-SAB implementation and expect this to improve with a resultant reduction in duration of bacteremia, length of stay, readmission rates, and mortality. In turn, this will translate into cost savings for the health care system.
Eligibility
Inclusion Criteria3
- Age greater than 18 years at the time of hospital admission
- Confirmed S. aureus bacteremia by blood culture performed at a laboratory in Alberta, Canada
- Admitted to a designated acute care site in Alberta, Canada
Exclusion Criteria3
- The treating team believes death is imminent or inevitable .
- GCD are C-level within 48 hours of admission.
- The patient is transferred in from an out-of-province acute care center with a pre-existing SAB diagnosis.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Activation of SAB clinical care pathway within EMR system.
Locations(101)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06338176